Nanoceria Inhibit the Development and Promote the Regression of Pathologic Retinal Neovascularization in the Vldlr Knockout Mouse
2011

Nanoceria Prevent Retinal Neovascularization in Mice

Sample size: 9 publication 10 minutes Evidence: high

Author Information

Author(s): Zhou Xiaohong, Wong Lily L., Karakoti Ajay S., Seal Sudipta, McGinnis James F.

Primary Institution: University of Oklahoma, College of Medicine

Hypothesis

The chronic rise of reactive oxygen species (ROS) is an Achilles' Heel for age-related macular degeneration (AMD) and other degenerative diseases, and targeting excess ROS can prevent downstream damage.

Conclusion

Nanoceria can inhibit the development of retinal neovascularization and promote regression of existing lesions in a mouse model of AMD.

Supporting Evidence

  • Nanoceria reduced oxidative stress markers in the retinas of Vldlr-/- mice.
  • Injection of nanoceria led to a significant decrease in VEGF levels in the retina.
  • Pathologic blood vessels in the Vldlr-/- retina were inhibited by nanoceria treatment.
  • Regression of existing vascular lesions was observed after nanoceria injection.

Takeaway

This study shows that tiny particles called nanoceria can help stop bad blood vessels from growing in the eyes of mice, which could help treat certain eye diseases.

Methodology

The study involved injecting nanoceria into the eyes of Vldlr knockout mice and measuring the effects on retinal neovascularization and oxidative stress.

Limitations

The study was conducted in a mouse model, which may not fully replicate human conditions.

Participant Demographics

Vldlr knockout mice were used as the primary subjects.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016733

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication